为了填补这一空白,来自以色列 Sheba Tel Hashomer 医疗中心等多个机构的研究人员 Rinat Bernstein - Molho、Ory Haisraely 等开展了一项重要研究。该研究成果发表在《Breast Cancer Research and Treatment》杂志上,为乳腺癌治疗领域带来了新的曙光。 研究方法:抽丝剥茧,探寻真相 研究人员从 2006 年 1 月至 2022 ...
and its incidence continues to rise. Postoperative radiotherapy for breast cancer can effectively improve local control rate and long-term survival rate. Radiotherapy has become the main technique for breast cancer treatment. How t...
目前,比较散发性异时性双乳癌(metachronous bilateral breast cancer, mbbc)的首发癌和对侧癌临床病理参数的研究较多 [ 7 - 13 ] ,但比较 brca1/2 突变双乳癌的首发癌和对侧癌临床病理参数罕见. brca1/2 突变乳腺癌还有自身的...
The second part is an overview of the therapeutic compounds used for breast cancer treatment targeting BRCA1, and thenatural food components that hold potential preventive effect against those types of breast cancer in which BRCA1 expression is either reduced or lacking. Further studies elucidating ...
[16] Payal Deepak Shah, et al.HOPE: Harnessing olaparib, palbociclib, and endocrine therapy for BRCA1/2-associated HR+, HER2- metastatic breast cancer.2024 ASCO abstract 10616. [17]Morganti S, Marra A, De Angelis C, et al. PARP Inhibitors for Breast Cancer Treatment: A Review. JAMA On...
Breast cancer, one of the most common serious malignancies affecting women, occurs in hereditary and sporadic forms. Hereditary breast cancer accounts for
第45卷第1期原子能科学技术V01.45,N o.12011年l flAtom i c Energy Sci ence and Technol ogyJ an.2011咖啡因联合辐射处理对人乳腺癌易感基因BRCAl 表达的影响李宁1’ 2’ 3” ,张红1’ 2’ 3” ,王燕玲1’ 2’ 3,周( 1.中国科学院近代物理研究所。甘肃兰州730000鑫1’ 2’ 3” ,郝冀方1’...
for breast cancer treatment. How to further reduce the adverse reactions of patients’ normal tissues and improve the curative effect of radiotherapy has become the research focus. This study aimed to investigate the expressions of human epidermal growth factor receptor 2 (HER2) and breast cancer ...
In establishing decision models in the treatment and prevention of breast cancer, it is important to evaluate patients' preferences for such interventions. The objectives of the present study were: (i) to characterize women's preferences for breast cancer treatments and BRCA1/BRCA2 testing, using ...
Identification of germline mutations associated with significant cancer susceptibility has the potential to change all aspects of an individual's care, from screening to cancer treatment. For example, women with germline mutations in BRCA1 and BRCA2 have markedly elevated risks of breast and ovarian ...